The synthesis of S 18986, a chiral AMPA receptor modulator, via catalytic asymmetric hydrogenation
β Scribed by Christopher J. Cobley; Elsa Foucher; Jean-Pierre Lecouve; Ian C. Lennon; James A. Ramsden; Gilles Thominot
- Publisher
- Elsevier Science
- Year
- 2003
- Tongue
- English
- Weight
- 156 KB
- Volume
- 14
- Category
- Article
- ISSN
- 0957-4166
No coin nor oath required. For personal study only.
β¦ Synopsis
The asymmetric hydrogenation of a dihydropyrrolo-benzothiadiazine dioxide 1 with a diphosphine ruthenium diamine catalyst has been used to synthesize the AMPA receptor positive modulator tetrahydropyrrolo-benzothiadiazine dioxide 2 (S 18986) in high enantiomeric excess. The use of factorial experimental design led to significant improvements in the process parameters and improved enantioselectivity.
π SIMILAR VOLUMES
Enantioselective reduction of pyrrolo-benzothiadiazine 6 using various chiral reducing agents has been studied and led to efficient synthesis of 8 (S 18986) which was established to be of (S) configuration by single crystal X-ray diffraction analysis. S 18986 is a potent and selective AMPA positive
Compound 7, a precursor in the synthesis of 4-methoxybalbergione, was prepared from compound 6 with an enantiomeric excess of 17 to 94% by asymmetric catalytic hydrogenation using rhodium or ruthenium chiral complexes. The best hydrogenation results were obtained using [Rh((S,S)-bdpp)(NBD)1 Cl04, an